RT20 + ELO5 – Research Peptide Blend (25mg)
Retatrutide 20mg + Eloralintide 5mg
RT20 + ELO5 is a dual-compound research blend combining retatrutide, an investigational triple-receptor agonist, with eloralintide, an investigational amylin-receptor agonist.
This combination is of scientific interest for studying metabolic regulation, appetite signaling, energy balance, and glucose metabolism.
Research Areas
Metabolic Research: Investigation of pathways involved in energy expenditure and metabolic regulation.
Appetite Signaling: Exploration of GLP-1, GIP, glucagon, and amylin receptor pathways.
Glucose Metabolism: Research into hormonal signaling associated with glucose regulation.
Combination Research: Investigation of interactions between incretin-related and amylin pathways.
Product Information
Product Name: RT20 + ELO5
Retatrutide: 20mg
Eloralintide: 5mg
Total Labeled Content: 25mg
Brand: 3A Labz
Important Notice
For laboratory research purposes only. Not for human consumption, injection, or clinical use.
Both compounds are investigational. The safety, effectiveness, and interactions of this specific combination have not been established. Product identity, purity, and potency require independent analytical verification.